Extra vaccine dose for immunodeficiency
The Public Health Agency recommends an extra dose of COVID-19 vaccine for those with a severely compromised immune system. The recommendation applies from 1 September.
Pfizer/Biontech vaccine recommended for children
The Public Health Agency of Sweden recommends that children aged 12-15 who are to be vaccinated against Covid-19 should only receive Pfizer/Biontech’s Comirnaty vaccine. The...
Changes related to entry into Sweden
The government has today presented a number of changes concerning entry into Sweden. The entry ban is extended for travel from outside the EU. The requirement for a negative...
New recommendation for testing for those who have been outside the Nordic region
Anyone who has been outside the Nordic region in the last 7 days should be tested for Covid-19 as soon as possible after returning home. In addition, special recommendations...
Proposal for measures to reduce the spread of Covid-19
The Swedish Public Health Agency has developed a proposal for infection control measures that will apply from 1st December. The measures concern how indoor public gatherings and...
Relief for vaccinated seniors
Vaccinated seniors may now return to a slightly more normal life with regard to contact with other people, writes the Swedish Public Health Agency.
Covid certificate for travelling to Sweden from the Nordic countries
The Public Health Agency proposes that the government introduce requirements for Covid certificates when entering Sweden also from the Nordic countries. Previously, the...
Booster dose for more groups
The Public Health Agency of Sweden recommends that everyone aged 65 years and older, as well as personnel in residential care homes, SÄBO, and in home healthcare and home care...
More to be vaccinated in Phase 2
The Public Health Agency has changed the order of priority for Covid-19 vaccination. Everyone over 65 years old will be vaccinated in Phase 2.
EMA recommends Covid-19 Vaccine AstraZeneca for authorisation in the EU
The European Medicines Agency (EMA) has recommended granting a conditional marketing authorisation for Covid-19 Vaccine AstraZeneca.